SEC Form 4 · accession 0000899243-16-010702
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott W Morrison
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 4, 2016 · 8:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $29.21 | Jan 4, 2016 | A | 30,000 | A | — | Jan 3, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The shares vest and become exercisable in 36 equal monthly installments, with the first installment on February 1, 2016. This option is subject to accelerated vesting upon a change of control of the Issuer.
- F2Not applicable.